Growth Metrics

C4 Therapeutics (CCCC) Shares Repurchased (2019 - 2026)

C4 Therapeutics' quarterly Shares Repurchased came in at $200000.0 in Q1 2026, up 29.03% year-on-year from $155000.0 in Q1 2025, and up 1328.57% quarter-over-quarter from $14000.0 in Q4 2025.

C4 Therapeutics has reported Shares Repurchased for 6 years, with the latest figure at $200000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Shares Repurchased rose 29.03% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $238000.0 (down 0.83% YoY), and the FY2025 full-year result was $193000.0, down 0.52% from the prior year.
  • Shares Repurchased for Q1 2026 stood at $200000.0, up from $14000.0 in the prior quarter.
  • The five-year high for Shares Repurchased was $200000.0 in Q1 2026, with the low at $14000.0 in Q4 2025.
  • Average Shares Repurchased over 4 years is $87125.0, with a median of $89500.0 recorded in 2023.
  • Year-over-year, Shares Repurchased surged 431.25% in 2024 and plunged 71.76% in 2025.
  • Tracing CCCC's Shares Repurchased over 4 years: stood at $16000.0 in 2023, then surged by 431.25% to $85000.0 in 2024, then slumped by 83.53% to $14000.0 in 2025, then surged by 1328.57% to $200000.0 in 2026.
  • The last three Shares Repurchased figures came in at $200000.0 (Q1 2026), $14000.0 (Q4 2025), and $24000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 336.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 794.30 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 C4 Therapeutics 561.03 Mn 325.36 Mn - 200,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 200,000.00
Mar 31, 2026 200,000.00
Dec 31, 2025 14,000.00
Dec 31, 2025 14,000.00
Sep 30, 2025 24,000.00
Sep 30, 2025 24,000.00
Mar 31, 2025 155,000.00
Mar 31, 2025 155,000.00
Sep 30, 2024 85,000.00
Sep 30, 2024 85,000.00
Mar 31, 2024 109,000.00
Mar 31, 2024 109,000.00
Sep 30, 2023 16,000.00
Sep 30, 2023 16,000.00
Mar 31, 2023 94,000.00
Mar 31, 2023 94,000.00
Dec 31, 2020 -16,000.00
Dec 31, 2020 -16,000.00
Sep 30, 2020 86,000.00
Sep 30, 2020 86,000.00
Dec 31, 2019 -10,000.00
Dec 31, 2019 -10,000.00